NEWS & VIEWS

Global private equity and venture capital news and research

Biotech sector suffers from PE investment slump, weakens for third month $

15 Aug 2014

biotechPrivate equity and venture capital investment in the biotechnology sector has weakened for the third successive month due to a dearth of dealmaking, new research suggests.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story. To read more, simply sign-up to our daily newsletter.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015